Condition
Cytochrome P450 CYP2D6 Enzyme Deficiency
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03052218Not ApplicableTerminated
Evaluation of Pupillometry for cyp2d6 Phenotyping in Children Treated With Tramadol
NCT02378220Not ApplicableCompleted
Pharmacogenetic Testing Among Home Health Patients
NCT02191358Completed
YouScript IMPACT Registry
NCT02428660Not ApplicableCompletedPrimary
Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
Showing all 4 trials